Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
about
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.Therapeutic benefits of nanoparticles in strokeRNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Current progress on microRNAs-based therapeutics in neurodegenerative diseases.Nano carriers for drug transport across the blood-brain barrier.Powering up the molecular therapy of RNA interference by novel nanoparticles.Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles.Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier.RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach.Polyglycerol-Based Copper Chelators for the Transport and Release of Copper Ions in Biological Environments.Zinc-imidazolate polymers (ZIPs) as a potential carrier to brain capillary endothelial cells
P2860
Q28066236-F2817045-07EE-44AF-8376-FD823D405357Q36410220-CB7383FA-F9C9-4FD9-938B-98FBB7D10BC6Q38401839-04F1F52F-8DA9-4A47-B1F0-5D5282FFE97FQ38515290-B9CE41FD-3489-4588-A0C2-BD25BE23008CQ38541950-E2412FBB-91A1-4EA9-B78A-D8FDF728212EQ38791303-8ECA5AC7-EA8C-4B28-A38C-6FB19199FFA9Q38820474-79331B19-5BDB-4841-A32A-B3702F946333Q38843670-DC485525-BF2F-4023-886F-8219D77B9E99Q41599384-2048AF01-82E5-413B-8BF8-727F4F3E0828Q42215950-8DD14F21-CC81-42A9-A43A-45C455AF7E9DQ45871459-E984DEA6-4C6A-45EB-8DB5-4E903E62CC17Q47933170-BB92EBFB-33F5-4919-BF52-83FB43640109Q52859832-6E5AC4C1-AF5A-4460-A818-FFBDDB7EB2FAQ57076402-BA96A270-A45E-46E4-8A6E-5CAD08F8B2AD
P2860
Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Nanoparticles and the blood-br ...... ards therapeutic significance.
@en
type
label
Nanoparticles and the blood-br ...... ards therapeutic significance.
@en
prefLabel
Nanoparticles and the blood-br ...... ards therapeutic significance.
@en
P2093
P2860
P1476
Nanoparticles and the blood-br ...... ards therapeutic significance.
@en
P2093
Aoife M O'Mahony
David J Mc Carthy
Meenakshi Malhotra
P2860
P304
P356
10.1007/S11095-014-1545-6
P577
2014-12-02T00:00:00Z